Ftse Mib
37.067,51
-0,15%
DAX
21.887,29
-0,12%
S&P 500
6.083,57
0,00%
NASDAQ
19.791,99
0,00%
Bitcoin
98.777,23
2,28%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 60 Degrees Pharmaceuticals Inc (SXTPW) 60 Degrees Pharmaceuticals Inc (SXTPW) Notizie

60 Degrees Pharmaceuticals Inc

SXTPW
0,0206
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:01:21
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/2/202522:41EDGAR2Form 8-K - Current report
06/2/202520:07GLOBE60 Degrees Pharma Announces Closing of $1.075 Million..
06/2/202516:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/2/202515:22GLOBE60 Degrees Pharma Announces $1.075 Million Registered Direct..
30/1/202523:30EDGAR2Form 8-K - Current report
30/1/202520:20GLOBE60 Degrees Pharma Announces Closing of $1.043 Million..
30/1/202514:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/1/202514:00GLOBE60 Degrees Pharma Announces $1.043 Million Registered Direct..
28/1/202522:05EDGAR2Form 8-K - Current report
28/1/202514:01GLOBE60 Degrees Pharma Announces IRB Approval of Phase II Study..
24/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202522:05EDGAR2Form 8-K - Current report
08/1/202514:02GLOBE60 Degrees Pharmaceuticals Enrolls First Patient in..
23/12/202414:57GLOBESixty Degrees Pharmaceuticals and Tufts Medical Center..
19/12/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202414:56GLOBE60 Degrees Pharmaceuticals Expands Tafenoquine Clinical..
09/12/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202420:31GLOBE60 Degrees Pharmaceuticals Announces Third Quarter 2024..
14/11/202419:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202423:26EDGAR2Form 8-K - Current report
15/10/202421:46EDGAR2Form DEF 14A - Other definitive proxy statements
08/10/202414:17EDGAR2Form 8-K - Current report
03/10/202415:02GLOBE60 Degrees Pharmaceuticals Inc. Announces ARAKODA®..
02/10/202416:56EDGAR2Form PRE 14A - Other preliminary proxy statements
01/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/9/202422:30EDGAR2Form S-3 - Registration statement under Securities Act of..
11/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:10EDGAR2Form 8-K - Current report
06/9/202414:59GLOBE60 Degrees Pharmaceuticals, Inc. Announces Closing of $4..
04/9/202414:00GLOBE60 Degrees Pharmaceuticals, Inc. Announces $4 Million..
28/8/202420:48GLOBE60 Degrees Pharmaceuticals, Inc. Regains Compliance with..
14/8/202417:01GLOBE60 Degrees Pharmaceuticals Announces Second Quarter 2024..
12/8/202415:12GLOBE60 Degrees Pharma Provides University of Kentucky with Right..
06/8/202415:26GLOBE60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse..
25/7/202415:02GLOBE60 Degrees Pharmaceuticals Awarded Contract with U.S. Army..
19/7/202414:29GLOBE60 Degrees Pharmaceuticals Signs Clinical Trial Agreements..
09/7/202412:31GLOBE60 Degrees Pharma Announces IRB Approval of Clinical Study..
27/6/202413:59GLOBEFirst Patient Enrolled in 60 Degrees Pharmaceuticals..
12/6/202423:26EDGAR2Form 8-K - Current report
11/6/202413:59GLOBE60 Degrees Pharmaceuticals Receives FDA Orphan Drug..
30/5/202420:15EDGAR2Form DEF 14A - Other definitive proxy statements
30/5/202413:59GLOBEEnrollment in 60 Degrees Pharmaceuticals Clinical Trial of..
22/5/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 0,0206

La tua Cronologia

NASDAQ
SXTPW
60 Degrees Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci